JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 August 2008

J Clin Pathol. Published Online First: 30 May 2008. doi:10.1136/jcp.2008.057067
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jcp.2008.057067v1
jcp.2008.057067v2
61/8/939    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Advani, A.
Right arrow Articles by Johnson, S. J
PubMed
Right arrow PubMed Citation
Right arrow Articles by Advani, A.
Right arrow Articles by Johnson, S. J
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MITOTANE
Medline Plus Health Information
*Personal Medical Records

Histopathology

Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review

Andrew Advani 1*, Suresh Vaikkakara 1, Muhammad Shafiq Gill 1, Chankramath S Arun 1, Simon H Pearce 1, Stephen G Ball 1, Robert A James 1, Tom WJ Lennard 1, Richard D Bliss 1, Richard Quinton 1 and Sarah J Johnson 1

1 Royal Victoria Infirmary, United Kingdom

* To whom correspondence should be addressed. E-mail: andrew.advani{at}utoronto.ca.

Accepted 8 May 2008


*   Abstract

Aims: Structured multi-centre efforts are needed if the prognosis of adrenocortical carcinoma (ACC) is to be improved. Data collection may be enhanced through standardised histopathological reporting using criteria such as the recently published Royal College of Pathologists (UK) Minimum Dataset (MDS). This study aimed to perform a clinicopathological review of the adult patients treated at our institution in the ten years preceding the MDS.

Methods: Case records were examined for all patients diagnosed with ACC between 1996 and 2006. Pathology was reviewed and compared to the RCPath(UK) MDS along with the original reports. A systematic evaluation of Ki-67 immunolabelling was also performed.

Results: Eleven patients with ACC were diagnosed and treated at our institution. Histopathological reporting according to the MDS identified more features of malignancy than in the original reports (p<0.02). The median number of microscopic criteria of malignancy was 7 (range 5-10), with ≥5 features occurring in all cases. The most commonly observed features of malignancy were diffuse architecture, <25% clear cells, confluent necrosis, abnormal mitoses and mitotic count ≥6 per 50 high power fields. Capsular invasion and ≥8 MDS criteria of malignancy were both associated with a worse outcome (each p<0.01). Median Ki-67 index was 19.0% (range 3.7-44.1%) and was not apparently related to survival.

Conclusions: Standardised criteria for histopathological reporting of ACC will improve the accuracy of data for cancer registration and may also assist in individual patient stratification. An elevated Ki-67 index is a feature of ACC although does not appear to predict individual patient survival.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.